Comparable Outcomes After Alternative and Matched Sibling Donor Hematopoietic Stem Cell Transplantation and the Role of Molecular Measurable Residual Disease for Acute Myeloid Leukemia in Elderly Patients-Reference-Cited by-同舟云学术

Comparable Outcomes After Alternative and Matched Sibling Donor Hematopoietic Stem Cell Transplantation and the Role of Molecular Measurable Residual Disease for Acute Myeloid Leukemia in Elderly Patients

Published:2021-09 Issue:9 Volume:27 Page:774.e1-774.e12
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Cho Byung-Sik,Yahng Seung-Ah,Min Gi-June,Park Silvia,Park Sung-Soo,Shin Seung-Hwan,Jeon Young-Woo,Yoon Jae-Ho,Lee Sung-Eun,Eom Ki-Seong,Kim Yoo-Jin,Lee Seok,Min Chang-Ki,Cho Seok-Goo,Kim Dong-Wook,Lee Jong Wook,Kim Myungshin,Kim Yonggoo,Kim Hee-Je

Funder

Korea Health Industry Development Institute

Ministry of Health and Welfare

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference52 articles.

1. Age and acute myeloid leukemia;Appelbaum;Blood,2006

2. Swedish Acute Leukemia Registry G. Acute myeloid leukemia in the real world: why population-based registries are needed;Juliusson;Blood,2012

3. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry;Juliusson;Blood,2009

4. Bridging strategies to allogeneic transplant for older AML patients;Hecker;Cancers (Basel),2018

5. The who, how and why: allogeneic transplant for acute myeloid leukemia in patients older than 60years;Wall;Blood Rev,2017

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced-toxicity conditioning regimen with low dose post-transplantation cyclophosphamide and low-dose anti-thymocyte globulin as graft-versus-host disease prophylaxis for haploidentical stem cell transplantation in older patients;Annals of Hematology;2024-05-29

2. Cellular therapies in older adults with hematological malignancies: A case-based, state-of-the-art review;Journal of Geriatric Oncology;2024-04

3. Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1;Bone Marrow Transplantation;2024-03-04

4. Comparison of Allogeneic Transplant Outcomes Between Matched Sibling Donors and Alternative Donors in Patients Over 50 Years of Age with Acute Myeloid Leukemia: 8/8 Allele-Matched Unrelated Donors and Unrelated Cord Blood Provide Better Leukemia-Free Survival Compared with Matched Sibling Donors During Nonremission Status;Transplantation and Cellular Therapy;2024-02

5. Reduced-toxicity conditioning regimen with low dose post-transplantation cyclophosphamide and low-dose anti-thymocyte globulin as graft-versus-host disease prophylaxis for haploidentical stem cell transplantation in older patients;2024-01-31